No insider purchase over the last 90 days. The latest, by ROSENFELD ERIC, was filed 01 Mar 2024.
This page follows insider dealings at Legato Merger Corp. III as filed with SEC (Form 4). Nothing new has been filed by managers of Legato Merger Corp. III in twelve months, the latest record being from 3 May 2024.
Since 2024, the database holds 1 purchase and 2 sales by insiders of the company. On the fundamentals side, the SEC filing (10-K) for the period ending 30 November 2025 lists net income at 7.9 m USD.
Elsewhere in the same market, our signals recently picked up insider purchases at Xenon Pharmaceuticals Inc. and Applied Digital Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended November 2025 · cache
4 of 4 declarations
Legato Merger Corp. III is a special purpose acquisition company focused on seeking investment targets across various sectors. It is listed on NASDAQ under the ticker XNAS.
Purchases our model currently ranks for the recommendations list.
All recommendations